{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:32:18Z","timestamp":1793410338693,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12471-018-1211-4","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T09:42:25Z","timestamp":1544694145000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Prevalence and cardiac phenotype of patients with a\u00a0phospholamban mutation"],"prefix":"10.1007","volume":"27","author":[{"given":"I. E.","family":"Hof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. G.","family":"Kranias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sanoudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"van Tintelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"van der Zwaag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"1211_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan DH, Kranias EG. Phospholamban: a\u00a0crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 2003;4:566\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1211_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA Zwaag Van der","year":"2012","unstructured":"Van der Zwaag PA, van Rijsingen IA, Asimaki A, et\u00a0al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 2012;14:1199\u2013207.","journal-title":"Eur J Heart Fail"},{"key":"1211_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3109\/07853890008998837","volume":"32","author":"K Frank","year":"2000","unstructured":"Frank K, Kranias EG. Phospholamban and cardiac contractility. Ann Med. 2000;32:572\u20138.","journal-title":"Ann Med"},{"key":"1211_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.yjmcc.2011.11.012","volume":"52","author":"K Haghighi","year":"2012","unstructured":"Haghighi K, Pritchard T, Bossuyt J, et al. The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na\/K-ATPase. J\u00a0Mol Cell Cardiol. 2012;52:773\u201382.","journal-title":"J Mol Cell Cardiol"},{"key":"1211_CR5","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias EG, Hajjar RJ. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ Res. 2012;110:1646\u201360.","journal-title":"Circ Res"},{"key":"1211_CR6","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1081578","volume":"299","author":"JP Schmitt","year":"2003","unstructured":"Schmitt JP, Kamisago M, Asahi M, et\u00a0al. Dilated cardiomyopathy and heart failure caused by a\u00a0mutation in phospholamban. Science. 2003;299:1410\u20133.","journal-title":"Science"},{"key":"1211_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1172\/JCI17892","volume":"111","author":"K Haghighi","year":"2003","unstructured":"Haghighi K, Kolokathis F, Pater L, et\u00a0al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a\u00a0critical difference between mouse and human. J\u00a0Clin Invest. 2003;111:869\u201376.","journal-title":"J Clin Invest"},{"key":"1211_CR8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","volume":"103","author":"K Haghighi","year":"2006","unstructured":"Haghighi K, Kolokathis F, Gramolini AO, et\u00a0al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci Usa. 2006;103:1388\u201393.","journal-title":"Proc Natl Acad Sci Usa"},{"key":"1211_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","volume":"48","author":"MM DeWitt","year":"2006","unstructured":"DeWitt MM, MacLeod HM, Soliven B, McNally EM. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J\u00a0Am Coll Cardiol. 2006;48:1396\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1211_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","volume":"6","author":"MG Posch","year":"2009","unstructured":"Posch MG, Perrot A, Geier C, et\u00a0al. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm. 2009;6:480\u20136.","journal-title":"Heart Rhythm"},{"key":"1211_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12471-013-0401-3","volume":"21","author":"PA Zwaag Van der","year":"2013","unstructured":"Van der Zwaag PA, van Rijsingen IA, de Ruiter R, et al. Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart\u00a0J. 2013;21:286\u201393.","journal-title":"Neth Heart J"},{"key":"1211_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.recesp.2014.11.017","volume":"68","author":"JM L\u00f3pez-Ayala","year":"2015","unstructured":"L\u00f3pez-Ayala JM, Boven L, van den Wijngaard A, Pe\u00f1afiel-Verd\u00fa P, van Tintelen JP, Gimeno JR. Phospholamban p.arg14del mutation in a\u00a0Spanish family with arrhythmogenic cardiomyopathy: evidence for a\u00a0European founder mutation. Rev Esp Cardiol. 2015;68:346\u20139.","journal-title":"Rev Esp Cardiol"},{"key":"1211_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/CIRCGENETICS.115.001263","volume":"9","author":"A Milano","year":"2016","unstructured":"Milano A, Blom MT, Lodder EM, et\u00a0al. Sudden cardiac arrest and rare genetic variants in the community. Circ Cardiovasc Genet. 2016;9:147\u201353.","journal-title":"Circ Cardiovasc Genet"},{"key":"1211_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvv127","volume":"107","author":"GS Liu","year":"2015","unstructured":"Liu GS, Morales A, Vafiadaki E, et al. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res. 2015;107:164\u201374.","journal-title":"Cardiovasc Res"},{"key":"1211_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","volume":"7","author":"IA Rijsingen Van","year":"2014","unstructured":"Van Rijsingen IA, van der Zwaag PA, Groeneweg JA, et\u00a0al. Outcome in phospholamban R14del carriers: results of a\u00a0large multicentre cohort study. Circ Cardiovasc Genet. 2014;7:455\u201365.","journal-title":"Circ Cardiovasc Genet"},{"key":"1211_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","volume":"36","author":"A Bhonsale","year":"2015","unstructured":"Bhonsale A, Groeneweg JA, James CA, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart\u00a0J. 2015;36:847\u201355.","journal-title":"Eur Heart J"},{"key":"1211_CR17","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.amjcard.2013.06.017","volume":"112","author":"JA Groeneweg","year":"2013","unstructured":"Groeneweg JA, van der Zwaag PA, Nordkamp OLR, et al. Arrhythmogenic right ventricular dysplasia\/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Am J Cardiol. 2013;112:1197\u2013206.","journal-title":"Am J Cardiol"},{"key":"1211_CR18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","volume":"14","author":"S Sepehrkhouy","year":"2017","unstructured":"Sepehrkhouy S, Gho JMIH, van Es R, et\u00a0al. Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. Heart Rhythm. 2017;14:1024\u201332.","journal-title":"Heart Rhythm"},{"key":"1211_CR19","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/jce.13094","volume":"27","author":"M Bourfiss","year":"2016","unstructured":"Bourfiss M, Te Riele AS, Mast TP, et\u00a0al. Influence of genotype on structural atrial abnormalities and atrial fibrillation or flutter in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. J\u00a0Cardiovasc Electrophysiol. 2016;27:1420\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1211_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et\u00a0al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"1211_CR21","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-018-1211-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-018-1211-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-018-1211-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:32:39Z","timestamp":1576197159000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-018-1211-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1007\/s12471-018-1211-4","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"13 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.E.\u00a0Hof, J.F.\u00a0van der Heijden, E.G.\u00a0Kranias, D.\u00a0Sanoudou, R.A.\u00a0de Boer, J.P.\u00a0van Tintelen, P.A.\u00a0van der Zwaag and P.A.\u00a0Doevendans declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}